Vir Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 05/15/2025 | 16.68 M | $108.11 M | 0.00% | 12.14% |
BLACKROCK, INC. | 05/02/2025 | 16.54 M | $107.19 M | 0.48% | 12.03% |
VANGUARD GROUP INC | 05/09/2025 | 12.81 M | $82.99 M | -2.46% | 9.32% |
STATE STREET CORP | 05/15/2025 | 5.73 M | $37.11 M | 12.86% | 4.17% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 2.68 M | $17.40 M | 40.14% | 1.95% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 2.30 M | $14.88 M | 4.48% | 1.67% |
ORBIMED ADVISORS LLC | 05/15/2025 | 2.25 M | $14.57 M | -30.15% | 1.64% |
FMR LLC | 05/12/2025 | 2.22 M | $14.36 M | 31,047.19% | 1.61% |
CITADEL ADVISORS LLC | 05/15/2025 | 1.62 M | $10.48 M | 496.18% | 1.18% |
MORGAN STANLEY | 05/15/2025 | 1.42 M | $9.23 M | 26.74% | 1.04% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 1.37 M | $8.91 M | 9.76% | 1.00% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 1.12 M | $7.26 M | -9.47% | 0.82% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 1.07 M | $6.92 M | 18.96% | 0.78% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 05/15/2025 | 1.06 M | $6.87 M | 37.73% | 0.77% |
NORTHERN TRUST CORP | 05/13/2025 | 930.32 K | $6.03 M | -0.01% | 0.68% |
SCHRODER INVESTMENT MANAGEMENT GROUP | 05/13/2025 | 840.43 K | $5.63 M | 100.00% | 0.61% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 791.61 K | $5.13 M | -13.82% | 0.58% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 742.67 K | $4.81 M | 43.61% | 0.54% |
ABRDN PLC | 05/13/2025 | 693.19 K | $4.49 M | 90.88% | 0.50% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 668.79 K | $4.33 M | 173.46% | 0.49% |
05/15/2025 | 611.61 K | $3.96 M | 100.00% | 0.44% | |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 596.52 K | $3.87 M | -1.25% | 0.43% |
HUDSON BAY CAPITAL MANAGEMENT LP | 05/14/2025 | 591.42 K | $3.83 M | -30.41% | 0.43% |
BAKER BROS. ADVISORS LP | 05/15/2025 | 542.54 K | $3.52 M | -49.98% | 0.39% |
D. E. SHAW & CO., INC. | 05/15/2025 | 506.70 K | $3.28 M | 0.94% | 0.37% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 500.00 K | $3.24 M | 100.00% | 0.36% |
UBS GROUP AG | 05/13/2025 | 477.40 K | $3.09 M | 98.82% | 0.35% |
SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 473.61 K | $3.07 M | -55.09% | 0.34% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 470.71 K | $3.05 M | 143.07% | 0.34% |
WOODLINE PARTNERS LP | 05/15/2025 | 466.74 K | $3.02 M | 245.64% | 0.34% |
PRINCIPAL FINANCIAL GROUP INC | 04/28/2025 | 459.34 K | $2.98 M | 2.69% | 0.33% |
JPMORGAN CHASE & CO | 05/12/2025 | 439.31 K | $2.85 M | -75.69% | 0.32% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 433.38 K | $2.81 M | -74.73% | 0.32% |
INVESCO LTD. | 05/12/2025 | 405.58 K | $2.63 M | 1.71% | 0.30% |
05/12/2025 | 358.58 K | $2.32 M | 100.00% | 0.26% | |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 05/14/2025 | 331.80 K | $2.15 M | 64.92% | 0.24% |
ALLIANZ ASSET MANAGEMENT GMBH | 05/05/2025 | 308.70 K | $2.00 M | 79.53% | 0.22% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 306.55 K | $1.99 M | 17.73% | 0.22% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 05/12/2025 | 292.58 K | $1.90 M | 27.60% | 0.21% |
TWINBEECH CAPITAL LP | 05/15/2025 | 291.42 K | $1.89 M | 100.00% | 0.21% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 290.68 K | $1.88 M | 87.64% | 0.21% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 272.54 K | $1.77 M | 10.84% | 0.20% |
AQR CAPITAL MANAGEMENT LLC | 05/15/2025 | 268.30 K | $1.74 M | 2,088.39% | 0.20% |
BALYASNY ASSET MANAGEMENT L.P. | 05/15/2025 | 266.01 K | $1.72 M | 368.45% | 0.19% |
CITIGROUP INC | 05/12/2025 | 260.52 K | $1.69 M | 41.34% | 0.19% |
CI PRIVATE WEALTH, LLC | 05/14/2025 | 258.38 K | $1.67 M | 0.33% | 0.19% |
AMERICAN CENTURY COMPANIES INC | 05/13/2025 | 257.62 K | $1.67 M | 11.66% | 0.19% |
WALLEYE CAPITAL LLC | 05/14/2025 | 250.97 K | $1.63 M | -42.24% | 0.18% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 250.00 K | $1.62 M | 290.22% | 0.18% |
EAGLE HEALTH INVESTMENTS LP | 05/12/2025 | 240.50 K | $1.56 M | 100.00% | 0.17% |
Vir Biotechnology, Inc. institutional Ownership - FAQ's
During the previous two years, 280 institutional investors and hedge funds held shares of Vir Biotechnology, Inc.. The most heavily invested institutionals were:
SB INVESTMENT ADVISERS (UK) LTD: 16.68 M
BlackRock, Inc.: 16.54 M
VANGUARD GROUP INC: 12.81 M
STATE STREET CORP: 5.73 M
DIMENSIONAL FUND ADVISORS LP: 2.68 M
GEODE CAPITAL MANAGEMENT, LLC: 2.3 M
67.40% of Vir Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 110.86 M shares in the last 24 months. This purchase volume represents approximately $599.74 M in transactions.